PCVX vs SO · $6.84B cap vs P/E 22, rev $29.55B
Vaxcyte Inc (PCVX) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Vaxcyte Inc (PCVX) is a biotechnology company listed on US.
Southern Company (SO) is a utilities - regulated electric company listed on US.
PCVX does not have a complete income-statement cache yet.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
PCVX currently screens at market cap $6.84B. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the PCVX and SO stock pages for the full models.
Not investment advice.